LIVE

 

News

With the opening of its building, MI-mAbs, the french demonstrator of immunotherapy antibodies embarks on a new phase of growth

  |   Presse releases

- A surface area of 1,500 square meters, this building, the property of Aix-Marseille Provence Metropolis was inaugurated on 5 July at the...

Read more 

Inauguration du bâtiment MI-mAbs le 5 juillet 2017

  |   Presse releases

MI-mAbs a inauguré le 5 juillet 2017 son nouveau bâtiment au cœur de Luminy

Read more 

AIS2017 | 5th Antibody Industrial Symposium

  |   Events

Plenary session and poster presentation on ADC

Read more 

MI-mAbs séléctionné pour présenter un projet au 2ème forum « DAY ONE », organisé conjointement par l’Institut de recherche Pierre Fabre et Cancer Bio Santé

  |   Events

Le 2ème forum « DAY ONE », organisé ce jour sur le site de l’Oncopole à Toulouse conjointement par l’Institut de recherche Pierre Fabre et...

Read more 

MI-mAbs signed a research contract to evaluate novel bispecific antibodies co-developed by Innate Pharma and Sanofi

  |   Presse releases

This contract follows the agreement announced by Innate Pharma and Sanofi last January on the development of novel bispecific antibodies...

Read more 

MI-mABs to attend the 11th edition of Biovision on April 13th and 14th in Lyon

  |   Events

Biovision World Life Science Forum is fostering a unique approach to meet, connect and collaborate between international decision-makers...

Read more 

MI-mAbs at the first edition of Toulouse Onco Week

  |   Events

MI-mAbs strengthened its positioning in the cancer field at the first edition of Toulouse Onco week

 

A new can’t miss event in the fight...

Read more 

Launch of MI-mAbs, pre-industrial demonstrator accelerating development of immunotherapy antibodies

  |   Presse releases

Signature of the consortium agreement between key players in science, translational research and industry of cancer and inflammation...

Read more